News & Articles

RNA controls can help avoid false negative results

The new cooperation aims to use BIORON's molecular biological tools and GENAPYS unique sequencing technology

Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Explore the advantages and applications of direct molecular testing for the diagnosis of bacterial and fungal pathogens

Watch this on-demand webinar to find learn more about the different methods of analyzing DNA content in a variety of foods

Watch this on-demand webinar to learn more about new updates of the NanoDrop One platform

From immunoassays and ELISAs to multi-mode microplate readers, discover the technologies making a difference for other scientists in your field

Hear opinions of leading scientists from Cornell University, University of Pittsburgh & GlaxoSmithKline

The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs

Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

How the NanoDrop One UV-Vis Spectrophotometer is bringing specificity to UV-Vis measurements

Dr. Bruce Budowle discusses how probabilistic genotyping is helping forensic labs identify low-level, degraded DNA samples

Join us Monday, November 16, to explore the advantages and applications of direct molecular testing

Which new products made the most difference to your lab work this year?

INTEGRA’s VIAFILL bulk reagent dispenser is said to be the perfect complement to the ThermoFisher Kingfisher system

Discover the advantages of 3D-bead-beating technology for the extraction and protection of high-quality nucleic acids, in this on-demand webinar

Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel